Suggestions
Yi Li
VC Investor and Alzheimer’s Disease Researcher
Professional Background
Yi (Lily) Li has a robust background in pharmaceutical sciences and extensive experience in the pharmaceutical industry. With roles spanning the fields of formulation science, pharmaceutical chemistry, and quality control, she has built a diverse skill set that has enabled her to contribute effectively to various organizations within the sector. Presently, she serves as a Principal at Sixty Degree Capital, where she leverages her expertise to facilitate advancements in pharmaceutical development and innovation. Her keen interest in pharmaceutical R&D positions her as a valuable asset in any team aiming to push the boundaries of drug development.
Lily’s past positions reflect her commitment to excellence and her passion for the pharmaceutical field. She has operated as a Board Observer for several notable biopharmaceutical companies, including Rgenix, Inc., Libra Therapeutics, and Antios Therapeutics. In these capacities, she has utilized her deep understanding of the industry to provide insights and guidance that help shape corporate strategies and scientific endeavors. Her earlier experience as a Pharmaceutical Scientist at Covar Pharmaceuticals Inc. and as a Formulation Scientist at 广州朗圣药业有限公司 further solidified her technical capabilities, allowing her to excel in the complexities of drug formulation and development.
Education and Achievements
Lily Li’s educational background is impressive and multifaceted. She holds a PhD in Pharmaceutical Sciences from the University of Toronto, where she honed her research skills and developed a profound understanding of the science behind drug formulation and delivery. Furthermore, she also earned a Master of Science in Pharmaceutical Sciences from the same esteemed institution, complementing her doctoral studies with a strong foundation in both theoretical and practical aspects of the field.
Before her advanced studies, Lily completed her Bachelor's Degree in Pharmaceutical Chemistry at the University of Toronto. This early academic investment laid the groundwork for her current expertise and passion for the pharmaceutical industry.
In addition to her pharmaceutical pursuits, she also pursued a Bachelor's Degree in European History, showcasing her intellectual curiosity and diverse academic interests. This breadth of knowledge not only enriches her professional interactions within pharmaceutical circles but also adds a unique perspective to her analytical and critical thinking skills.
Lily’s educational journey began at Guangzhou Zhixin High School, where she established a strong foundation in science and humanities, paving the way for her future academic endeavors. She further enhanced her global perspective by studying Criminology at the prestigious University of Oxford, an experience that deepened her understanding of social issues and ethical considerations within scientific research and practice.
Achievements
Throughout her career, Yi Li has achieved a number of significant milestones that underline her capabilities as a professional in the pharmaceutical sector. Her work as a Board Observer has equipped her with the insight required to navigate complex industry challenges and regulatory environments, allowing companies to optimize their R&D processes effectively.
Moreover, as a former Research Assistant under the guidance of Prof. Shana O. Kelley at the University of Toronto, she played a crucial role in advancing critical research projects, contributing valuable findings that furthered the field of pharmaceutical sciences. As a Researcher for Prof. Jui-I Chao at National Chiao Tung University, she expanded her research acumen and collaborated on innovative studies that sought to enhance drug efficacy and safety.
Yi's diverse career path also includes roles across several organizations where she contributed to quality control at Ranbaxy and assisted in ophthalmic care at Dr. Joseph JK. Ma’s Clinic in Toronto, ON. Each of these positions has equipped her with a unique perspective on the pharmaceutical industry and the importance of maintaining high standards in drug development and patient care.
In addition to her practical experiences, Lily is keenly aware of the necessity for efficient processes within pharmaceutical research and development, making her an advocate for innovation in technology that promotes both productivity and sustainability within R&D practices. Her ability to blend her scientific knowledge with her practical experiences positions her to significantly impact the field positively.
With an eagerness to continue evolving her skills, Yi (Lily) Li is set to make further strides in her professional journey, aiming to deepen her involvement in pharmaceutical R&D and advance her career in a manner that emphasizes efficiency while maintaining high standards of scientific integrity.
